While structured data is now commonly deidentified and used for a multitude of purposes, it’s only part of the story. Approximately 80% of patient data is unstructured. Important knowledge – such as why patients are improving, or worsening – is often hidden away in unstructured text, requiring natural language processing (NLP) to help extract it. Commercialization of both structured and unstructured data is possible while not distracting from a primary concern – maintaining a layer of protection for your patients.
Seemingly marginal insights captured in de-identified patient data can end up being highly significant, driving medical device innovation and greater advances in patient health (even outside the clinical trial setting).
By combining the best-in-class extraction power of Linguamatics Natural Language Processing (NLP) platform and the industry-leading data anonymization capabilities of Privacy Analytics’ Eclipse software, we’ve created an end-to-end privacy solution.
Having a single data privacy solution helps you drive enhanced analysis and gives you the most complete, ‘360-degree’ view of your data subjects while ensuring their privacy is properly protected.
Join IQVIA’s Linguamatics and Privacy Analytics teams, live, as we discuss:
- Why relying on structured data alone isn’t enough
- How a unified solution (NLP + De-identification) helps you safely extract and share more, better data
- Success stories from organizations that use both types of data
- How to bring the whole story together and commercialize on your data efforts
Who should attend:
Chief Medical Information Officers, Chief Information Officers, Chief Research Information Officers, VPs of Analytics, clinical researchers and innovation teams at healthcare systems, cancer centers, and children’s hospitals
Venue: Online, United Kingdom
When: Wednesday, October 14, 2020, 2020
Time: 11:00am EDT; 8:00am PDT; 4:00pm BST; 5:00pm CEST.
Duration: 60 minutes.